李斯妮，护理学博士
湘雅护理学院，特聘副教授
研究方向：精神卫生与心理护理/母婴与儿童护理学/卫生经济学与模型构建
教育背景
2022年-2025年 香港中文大学那打素护理学院 护理学 博士
2021年-2022年 英国谢菲尔德大学医学院 卫生经济学与模型构建 硕士
2019年-2022年 中南大学湘雅护理学院 护理学 硕士
工作经历
2025年10月-至今 特聘副教授
研究方向
1. 特需儿童/青少年家庭社会心理干预与健康促进
2. 围产期妇女及家庭心理支持与健康促进
3. 卫生经济学与模型构建
4. 医疗教学改革与管理
奖励荣誉
1. Michael J. Asher Student Dissertation Award offered by the Association for Contextual Behavioral Science (2025)
2. Student World Conference Scholarship offered by the Association for Contextual Behavioral Science (2025)
3. The Chinese University of Hong Kong Outstanding Academic Award (2024-2025)
4. 新时代健康科普作品征集大赛（湖南赛区）优秀及入围作品（2024年）
5. 湖南省优秀科普作品二等奖（2024年）
6. CUHK Vice-Chancellor’s PhD Scholarship Scheme (2022-2025)
科研项目
1. 国际语境行为科学协会基金会财务基金 (Association for Contextual Behavioral Science Foundation) 立项 “A randomized controlled trial of an ACT-based parenting program for parents and children with autism spectrum disorder”
2. 湖南省研究生自主探索创新基金项目“基于离散事件模拟的类风湿关节炎动态决策分析模型的构建及卫生经济学评价研究”
3. 中南大学研究生创新课题“基于离散事件模拟的类风湿关节炎动态决策分析模型的构建及卫生经济学评价研究”
代表性成果
1. Yang, L., Li, S. N.*, Wang, Q., Pan, S., & Zhao, W. (2025). Unveiling the Relationships of Professional Identity, Values and Communication Competence in Nursing Students' Clinical Practice Behaviours: A Cross-Sectional Study and Mediation Model Analysis. Nursing open, 12(7), e70270. https://doi.org/10.1002/nop2.70270
2. Li, S. N.; Yang, L.; Tang, S. Q.; Wang, Q. Y.; Xie, J.; Cao, H.; Zhao, W. (2025). Validation and Refinement of the Short Version of Perinatal Grief Scale in Chinese Women who Experience Perinatal Loss: A Psychometric Study. Clinical Psychology & Psychotherapy, 32(2), e70067. https://doi.org/10.1002/cpp.70067
3. Jiao, Xie; Li, Yang, Li, S. N.*. (2025). The roles of parental psychological flexibility, mindful awareness, and self-compassion on mental health and self-efficacy in parents of children with or without congenital hearing loss: An analysis of the parallel mediation model. Nursing Open, 12(4), e70180. https://doi.org/10.1002/nop2.70180
4. Li, S. N.; Chien, W. T.; Lam, K. K. (2024). Effects of an acceptance and commitment-based parenting program for parents of children with autism spectrum disorder on parental stress and other parent and children health outcomes: a pilot randomized controlled trial. Autism, 29(6), 1524–1539. https://doi.org/10.1177/13623613241311323
5. Li, S. N.; Chien, W. T.; Lam, K. K.; Chong, Y. Y.; Gloster, A. T. (2024). Psychometric properties of the Chinese version of the Psy-Flex among parents of children with autism spectrum disorder. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-024-06610-0
6. Li, S. N.; Yang, L.; Wang, Q. Y.; Pan, S.; Xiao, M. H.; Xie, J. (2024). Effectiveness of Nonpharmacological Interventions for Improving the Mental Health and Other Psychosocial Outcomes of Parents with Perinatal Loss: A Systematic Review and Meta-Analysis, Depression and Anxiety, 2181544, 13 pages. https://doi.org/10.1155/2024/2181544
7. Li, S. N., Chien, W. T., Lam, S. K. K., Chen, Z. Y., & Ma, X. (2024). Effectiveness of parent-focused interventions for improving the mental health of parents and their children with autism spectrum disorder: A systematic review and meta-analysis. Research in Autism Spectrum Disorders, 114, 102389. https://doi.org/10.1016/j.rasd.2024.102389
8. Li, S. N., Chen, Z., Yong, Y., Xie, J., & Li, Y. (2023). Effectiveness of acceptance and commitment therapy-based interventions for improving the psychological health of parents of children with special health care needs: A systematic review and meta-analysis. Comprehensive Psychiatry, 127, 152426. https://doi.org/10.1016/j.comppsych.2023.152426
9. Li, S. N., Yong, Y., Li, Y., Li, J., & Xie, J. (2023). Cognitive-Based Interventions for Improving Psychological Health and Well-Being for Parents of Children with Developmental Disabilities: A Systematic Review and Meta-analysis. Journal of Autism and Developmental Disorders, 54(9), 3316–3335. https://doi.org/10.1007/s10803-023-06063-x
10. Xie, J., Li, S. N.*, Li, Y., & Li, J. (2023). Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer. BMC Health Services Research, 23(1), 706. https://doi.org/10.1186/s12913-023-09728-6
11. Li, S. N.., Wan, X., Peng, L. B., Li, Y. M., & Li, J. H. (2023). Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma. BMC Health Services Research, 23(1), 49. https://doi.org/10.1186/s12913-023-09058-7
12. Li, S. N., Li, J., Peng, L., Li, Y., & Wan, X. (2021). Cost-Effectiveness of Nivolumab Plus Cabozantinib Versus Sunitinib as a First-Line Treatment for Advanced Renal Cell Carcinoma in the United States. Frontiers in pharmacology, 12, 736860. https://doi.org/10.3389/fphar.2021.736860
13. Li, S. N., Li, J., Peng, L., Li, Y., & Wan, X. (2021). Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies. Frontiers in pharmacology, 12, 718014. https://doi.org/10.3389/fphar.2021.718014
14. Li, S. N., Li J, Peng L, Tan C, Zeng X, Peng C, et al. (2021). First-line Daratumumab in Addition to Chemotherapy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant Ineligible: A Cost-Effectiveness Analysis. Clinical Therapeutics, 43(7), 1253–1264.e5. https://doi.org/10.1016/j.clinthera.2021.05.015
15. Li, S. N., Li J, Peng L, Li Y, Wan X. Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer. Frontiers in Oncology, 11, 684073. https://doi.org/10.3389/fonc.2021.684073
16. Li, S. N., Li J, Peng L, Li Y, Wan X. (2021). Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China. Rheumatology and Therapy, 8(2), 863–876. https://doi.org/10.1007/s40744-021-00308-w
17. Li, S. N., Li J, Peng L, Li Y, Wan X. (2021). Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure. Rheumatology and Therapy, 8(2), 775–791. https://doi.org/10.1007/s40744-021-00300-4
18. Li, S. N., Peng L, Tan C, Zeng X, Wan X, Luo X, et al. (2020). Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China. PloS One, 15(5), e0232240. https://doi.org/10.1371/journal.pone.0232240
学术兼职
湖南省医疗保障研究会药物经济专业委员会常务委员
湖南省药师协会药物经济研究专业委员会委员
联系方式
lisini_audrey@csu.edu.cn
